Tangible Scientific is addressing key challenges in drug discovery with its technology-enabled compound management platform.

A new preclinical study has shown that reducing the protein HDAC11 could slow muscle degeneration in Duchenne muscular dystrophy, providing a potential target for future therapies.

Learn about the importance of quantum chemistry in targeting mutant proteins effectively in drug discovery for ...

Explore the debate surrounding animal testing as new methods may jeopardise patient safety if not properly validated.

New research shows chronic alcohol use rewires gene activity in human brain regions that control reward and decision-making, ...

Location: Hilton London Kensington 179-199 Holland Park Avenue London W11 4UL United Kingdom ...

Explore how ABB Robotics is reshaping laboratory automation with AI and collaborative robotics at SLAS 2026 in Boston.

Discover the collaboration between Synthace and Charles River to enhance assay development and improve reproducibility in ...

Explore how boron compounds are revolutionising drug development with new stable boron-fluorine compounds for better ...

Explore groundbreaking gene-editing therapy for kidney disease, offering hope to those with polycystic kidney disease.

Explore AI in drug discovery and its journey from promise to proof in 2025 with significant achievements and challenges faced.

Explore innovative anxiety and PTSD treatments with Addex Therapeutics' groundbreaking research on mGlu7 modulators.